
Sabine Grimm, PhD, MSc, examined how this multidisciplinary process can be harnessed to the benefit of decision-makers, guideline developers, payers, and patients.
On Sunday, speakers will explain how to choose the appropriate statistical analysis for the research question at hand. On Monday, presenters will introduce latent structures and latent variable models.
Panelists, including Joan Merrill, MD, will discuss data from preliminary studies of chimeric antigen receptor (CAR) T-cell therapy treatment for lupus and review potential future therapies, including autologous CAR-T cells targeting alternative antigens, allogeneic cell therapy treatments, and strategic cell-harnessing treatments.
Eliza Pei-Suen Tsou, PhD, will discuss the role of senescence and the scleroderma vasculature as part of a session on the central role of vasculopathy in systemic sclerosis.
Panelists, including Lesley Davila, MD, will guide attendees through strategies to maximize the tools of two electronic medical record (EMR) platforms to reduce time spent on non-patient-facing work.